Inside BioThrust: The Startup Scaling Cell Therapy with Bubble-Free Bioreactors cover art

Inside BioThrust: The Startup Scaling Cell Therapy with Bubble-Free Bioreactors

Inside BioThrust: The Startup Scaling Cell Therapy with Bubble-Free Bioreactors

Listen for free

View show details

About this listen

In this episode of Biology Career Insights, we sit down with Patrick Bongartz, Co-Founder and CEO of BioThrust, a biotech startup revolutionizing cell culture processes with its patented bubble-free, low-shear bioreactor technology.Patrick takes us through his inspiring journey—from his academic foundation at RWTH Aachen University to founding BioThrust in 2020, and how he and his co-founders tackled key challenges in bioprocessing. We talk about the technical innovation behind their ComfyCell system, the evolution of cell and gene therapy, and what it means to build a startup in today’s complex biotech landscape.This candid conversation covers:Patrick’s academic and entrepreneurial backgroundThe story and mission behind BioThrustDeep dive into bioprocessing innovation: bubble-free aerationTrends in MSC, CAR-T, and HEK scale-upInsights from ISCT and ASGCT 2025 conferencesReflections on co-founder dynamics, fundraising, and navigating uncertainty in biotechAdvice for aspiring scientists and biotech entrepreneurs✨ A huge thanks to Patrick for generously sharing his story and insights!🔔 Subscribe for more conversations with biotech leaders: https://youtube.com/@bcipodcast


📩 Learn more or get in touch: www.bcipodcast.eu

What listeners say about Inside BioThrust: The Startup Scaling Cell Therapy with Bubble-Free Bioreactors

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.